Health Condition 1: C506- Malignant neoplasm of axillary tail of breast Health Condition 2: C509- Malignant neoplasm of breast of unspecified site Health Condition 3: C501- Malignant neoplasm of central portion of breast Health Condition 4: C503- Malignant neoplasm of lower-innerquadrant of breast Health Condition 5: C505- Malignant neoplasm of lower-outerquadrant of breast Health Condition 6: C500- Malignant neoplasm of nipple and areola Health Condition 7: C508- Malignant neoplasm of overlappi
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient undergoing reconstructive breast surgery belonging to American Society of Anesthesiologists (ASA) physical status 1- 3
Exclusion criteria
Exclusion criteria: 1)Patients not willing to be a part of the study. 2)Patients allergic to local anaesthetic drug. 3)Patients with infection in the area of planned injection site. 4)Patients with cognitive dysfunction, dementia, preexisting communication disorders 5) Emergency surgeries. 6) Patients currently prescribed with ongoing preoperative opioid analgesics or who had current acute pain being treated or chronic pain syndromes or those receiving medical therapies considered to result in tolerance to opioid, deranged organ system function in the form of altered coagulation profile, severe hepatic and renal dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score evaluation among the groups.Timepoint: Immediate post operative period till hospital discharge | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of recovery patient satisfaction and opioid consumptionTimepoint: Immediate post operative period till hospital discharge | — |
Countries
India
Contacts
HCG Hospital